This article was originally published in The Gray Sheet
Executive SummaryPrices $56 mil. secondary offering of 3.5 mil. shares at $16 each. Slightly smaller than the 4 mil. share offering originally anticipated, the proceeds will be used to fund the ongoing rollout of the LADARVision tracker-assisted ophthalmic excimer laser system and for general corporate purposes (1"The Gray Sheet" July 26, p. 5). The offering is being managed by Hambrecht & Quist LLC, U.S. Bancorp Piper Jaffray and Dain Rauscher Wessels
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.